Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eton Pharmaceuticals, Inc.
  6. News
  7. Summary
    ETON   US29772L1089

ETON PHARMACEUTICALS, INC.

(ETON)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
3.260 USD   +2.19%
05/12TRANSCRIPT : Eton Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12ETON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/12Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eton Pharmaceuticals, ANI Pharmaceuticals Launch Carglumic Acid Tablets for Hyperammonemia

12/20/2021 | 10:44am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ANI PHARMACEUTICALS, INC. 3.14% 30.86 Delayed Quote.-33.03%
ETON PHARMACEUTICALS, INC. 2.19% 3.26 Delayed Quote.-24.01%
RECORDATI 2.53% 42.56 Delayed Quote.-24.67%
All news about ETON PHARMACEUTICALS, INC.
05/12TRANSCRIPT : Eton Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12ETON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
05/12Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 3..
CI
05/12Earnings Flash (ETON) ETON PHARMACEUTICALS Reports Q1 Revenue $2.2M
MT
05/12Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
GL
05/12Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
AQ
05/12Eton Pharmaceuticals, Inc. Provides Revenue Guidance for the Full Year 2022
CI
05/03Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12..
GL
05/03Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12..
AQ
04/11ETON PHARMACEUTICALS : Appoints James Gruber as Chief Financial Officer - Form 8-K
PU
More news
Analyst Recommendations on ETON PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 30,7 M - -
Net income 2022 -1,18 M - -
Net Debt 2022 - - -
P/E ratio 2022 -72,4x
Yield 2022 -
Capitalization 82,2 M 82,2 M -
Capi. / Sales 2022 2,68x
Capi. / Sales 2023 1,53x
Nbr of Employees 17
Free-Float 80,1%
Chart ETON PHARMACEUTICALS, INC.
Duration : Period :
Eton Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ETON PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,26 $
Average target price 10,50 $
Spread / Average Target 222%
EPS Revisions
Managers and Directors
Sean E. Brynjelsen President, Chief Executive Officer & Director
James Gruber Chief Financial Officer
Norbert G. Riedel Chairman
Charles J. Casamento Independent Director
Paul Victor Maier Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ETON PHARMACEUTICALS, INC.-24.01%82
MERCK KGAA-24.05%79 076
KYOWA KIRIN CO. LTD.-13.65%11 377
SK BIOPHARMACEUTICALS CO., LTD.-11.21%5 308
YUHAN CORPORATION-5.80%3 126
BETTA PHARMACEUTICALS CO., LTD.-43.32%2 808